Yale University

The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.

TitleThe impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.
Publication TypeJournal Article
Year of Publication2011
AuthorsSullivan, Lynn E., Michael Botsko, Chinazo O. Cunningham, Patrick G. O'Connor, David Hersh, Jennifer Mitty, Paula J. Lum, Richard S. Schottenfeld, and David A. Fiellin
Corporate AuthorsBHIVES Collaborative
JournalJournal of acquired immune deficiency syndromes (1999)
Volume56 Suppl 1
PaginationS54-61
Date Published2011 Mar 1
ISSN1944-7884
KeywordsAdult, Anti-HIV Agents, Buprenorphine, Cocaine-Related Disorders, Female, HIV Infections, Humans, Male, Middle Aged, Naloxone, Narcotic Antagonists, Needle Sharing, Opiate Substitution Treatment, Opioid-Related Disorders, Prospective Studies, Risk Factors, Treatment Outcome, Unsafe Sex
AbstractCocaine use is common in opioid-dependent HIV-infected patients, but its impact on treatment outcomes in these patients receiving buprenorphine/naloxone is not known.
DOI10.1097/QAI.0b013e3182097576
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links